Jason R Young

14PUBLICATIONS
69CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Econometric and statistical methodsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 18, 2023
BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis.

Aldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag

|Aug 17, 2023
Metabolic PET/CT analysis of aggressive Non-Hodgkin lymphoma prior to Axicabtagene Ciloleucel CAR-T infusion: predictors of progressive disease, survival, and toxicity.

William G Breen, Jason R Young, Matthew A Hathcock

|Feb 23, 2023
Bayesian penalized likelihood PET reconstruction impact on quantitative metrics in diffuse large B-cell lymphoma.

Jason R Young, Vamshi K Mugu, Geoffrey B Johnson

|May 03, 2022
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.

Sanjal H Desai, Levi Pederson, Betsy LaPlant

|Feb 08, 2021
18F-FDG PET/CT of hepatocellular adenoma subtypes and review of literature.

Jason R Young, Rondell P Graham, Sudhakar K Venkatesh

|Nov 24, 2020
How We Do It: A Multidisciplinary Approach to 177Lu DOTATATE Peptide Receptor Radionuclide Therapy.

Brian J Burkett, Ayca Dundar, Jason R Young

Pageof 3

Frequent Collaborators

7 joint publications

N Nora Bennani

6 joint publications

Jithma P Abeykoon

6 joint publications

Ronald S Go

6 joint publications

Mithun V Shah